TOMSK, RUSSIA / RankWire.AI / – Russian researchers have created and evaluated a bioactive surface layer for titanium orthopedic devices. The coating incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds associated with nitric oxide production. Laboratory experiments revealed that human mesenchymal stem cells exhibited greater survival rates on coated titanium compared to uncoated metal. The team also studied surface chemistry, hardness, thickness, and wettability. The peer-reviewed research focused on how various gas mixtures affected the coating’s properties and biological response.

Researchers at Tomsk Polytechnic University applied the coatings via reactive magnetron sputtering within a vacuum chamber. They used a hydroxyapatite target and altered the nitrogen and argon gas ratio during deposition. The team tested five different gas conditions, including pure nitrogen and pure argon. Each scenario led to measurable differences in the coating. They evaluated surface structure, chemical makeup, mechanical properties, and liquid contact. Coated titanium samples were then exposed to human mesenchymal stem cells under controlled laboratory settings.
The findings indicated that argon content affected several physical features of the coatings. Higher argon levels produced thicker, denser, and harder layers. Chemical analyses detected nitrogen-carbon and nitrogen-oxygen bonds in the modified surfaces. Cell survival was compared across coated and uncoated titanium samples. Results showed that the coated surfaces significantly enhanced cell viability during the experiment. The team also analyzed gene activity related to early bone cell development to explore how the materials influenced cell behavior.
Enhanced cell survival with coated titanium surfaces
Researchers observed that increased nitrogen levels altered the activity of certain genes associated with early bone-cell differentiation. These changes appeared after seven days of cell growth. Despite these genetic shifts, the cells maintained their capacity to develop into bone tissue. The study did not include tests on human subjects nor did it measure clinical outcomes from implantable devices. Consequently, the results describe laboratory performance rather than confirmed benefits for patients receiving joint replacements or other orthopedic implants.
Scientists from Immanuel Kant Baltic Federal University and Siberian State Medical University conducted the biomedical assessments. Researchers from Saint Petersburg State University also participated in the broader project. The research explored how coating composition influences both material characteristics and cell responses. Hydroxyapatite is commonly studied for medical coatings due to its calcium phosphate structure, which resembles the mineral component of human bone. The team used this base material while varying nitrogen exposure during the coating process.
Future research will assess longer-term biological effects
The researchers plan additional laboratory and biological tests after the initial seven-day evaluation. They aim to observe stem cells for periods ranging from 10 to 28 days. They also intend to measure how quickly the coatings break down. Another part of the future work involves tracking nitric oxide release into tissues in living organisms. These tests were not part of the published study. The current results are limited to laboratory measurements and cell experiments with coated titanium samples.
This study provides insights into how nitrogen and argon ratios influence calcium phosphate coatings on titanium implants. It documents changes in coating thickness, density, hardness, chemical bonds, and cellular responses. Coated samples consistently supported better stem-cell survival than untreated titanium in laboratory conditions. Still, the research is preclinical and does not confirm safety or effectiveness in humans. Further studies will examine properties not measured here, such as long-term cell behavior and nitric oxide release.
